Product Program year 2025 Source: CMS Open Payments

Tryngolza

Drug Cardiology

NDC 71860-101-01

Open in the dashboard

General payments

$144,712

1,066 payments

Research payments

$618,913

4 payments

Through program year 2025, $144,712 in general payments and $618,913 in research payments were reported against Tryngolza (Cardiology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $144,712 1,066
2025 Research $618,913 4

Breakdown

Who paid General payments · program year 2025
  1. Ionis Pharmaceuticals, Inc. $144,712 1,066 payments
Top recipients General payments · program year 2025
  1. Seth Baum Cardiovascular Disease · Boca Raton, FL $34,152 24% · 11 payments
  2. Andres Gelrud Gastroenterology · Miami, FL $19,371 13% · 7 payments
  3. James Underberg Internal Medicine · New York, NY $15,926 11% · 11 payments
  4. Jamie Dwyer Nephrology · Nashville, TN $12,350 9% · 3 payments
  5. David Davidson Cardiovascular Disease · Bannockburn, IL $8,659 6% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Cardiovascular Disease Internal Medicine $63,211 45% · 204 practitioners
  2. Gastroenterology Internal Medicine $19,701 14% · 10 practitioners
  3. Internal Medicine $17,652 12% · 47 practitioners
  4. Endocrinology, Diabetes & Metabolism Internal Medicine $15,776 11% · 157 practitioners
  5. Nephrology Internal Medicine $12,412 9% · 4 practitioners

The top 5 of 41 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $56,702 39% · 82 recipients
  2. New York $17,972 12% · 79 recipients
  3. Illinois $14,044 10% · 34 recipients
  4. California $13,591 9% · 151 recipients
  5. Tennessee $12,448 9% · 5 recipients

The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,066 general · 4 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record